Skip to main content
. Author manuscript; available in PMC: 2013 May 22.
Published in final edited form as: Am J Clin Oncol. 2011 Oct;34(5):454–459. doi: 10.1097/COC.0b013e3181f47aa4

TABLE 3.

Immunohistochemical Expression in Clear Cell and Nonclear-cell Sarcomatoid RCC (n=28)

Staining Grade
Clear-cell RCC (n=24), No. (%)
Nonclear-cell RCC (n=4), No. (%)
Antibody 0 1 2 3 0 1 2 3
CA9 2 (8) 1 (4) 1 (4) 20 (83) 4 (100) 0 (0) 0 (0) 0 (0)
HIF-1α 6 (25) 3 (13) 4 (17) 11 (46) 4 (100) 0 (0) 0 (0) 0 (0)
p-4E BP1* 8 (35) 2 (9) 3 (13) 10 (43) 4 (100) 0 (0) 0 (0) 0 (0)
p-S6* 4 (18) 2 (9) 3 (9) 14 (61) 2 (50) 2 (50) 0 (0) 0 (0)
*

Staining not analyzed in 1 of 24 clear-cell tumors.

CA9 indicates carbonic anhydrase IX; HIF-1α, hypoxia-inducible factor-1α; p-4E BP1, phosphorylated eukaryotic initiation factor 4E-binding protein 1; pS6, phosphorylated protein S6 kinase 1; RCC, renal cell carcinoma.